These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23581871)

  • 41. Quetiapine for the treatment of trichotillomania.
    Crescente Junior JA; Guzman CS; Tavares H
    Braz J Psychiatry; 2008 Dec; 30(4):402. PubMed ID: 19142421
    [No Abstract]   [Full Text] [Related]  

  • 42. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quetiapine augmentation of sertraline in obsessive-compulsive disorder.
    Francobandiera G
    J Clin Psychiatry; 2002 Nov; 63(11):1046-7. PubMed ID: 12469688
    [No Abstract]   [Full Text] [Related]  

  • 44. Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.
    Findling RL; Pathak S; Earley WR; Liu S; DelBello M
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):490-501. PubMed ID: 24024534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperglycemic hyperosmolar state associated with low-dose quetiapine treatment in a patient with bipolar disorder.
    Chen WY; Chen CC; Hung GC
    Curr Drug Saf; 2011 Jul; 6(3):207-8. PubMed ID: 22122398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial.
    Pathak S; Findling RL; Earley WR; Acevedo LD; Stankowski J; Delbello MP
    J Clin Psychiatry; 2013 Jan; 74(1):e100-9. PubMed ID: 23419231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
    Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K
    J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quetiapine for treatment-resistant mania.
    Dunayevich E; Strakowski SM
    Am J Psychiatry; 2000 Aug; 157(8):1341. PubMed ID: 10910805
    [No Abstract]   [Full Text] [Related]  

  • 49. Neutropenia associated with the comedication of quetiapine and valproate in 2 elderly patients.
    Hung WC; Hsieh MH
    J Clin Psychopharmacol; 2012 Jun; 32(3):416-7. PubMed ID: 22561472
    [No Abstract]   [Full Text] [Related]  

  • 50. Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders.
    Prabhakar M; Haynes WG; Coryell WH; Chrischilles EA; Miller del D; Arndt S; Ellingrod VL; Warren L; Fiedorowicz JG
    Pharmacotherapy; 2011 Aug; 31(8):806-12. PubMed ID: 21923607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quetiapine augmentation in depressed patients with partial response to antidepressants.
    Olver JS; Ignatiadis S; Maruff P; Burrows GD; Norman TR
    Hum Psychopharmacol; 2008 Dec; 23(8):653-60. PubMed ID: 18816504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term remission of schizophrenia in an adolescent treated with quetiapine.
    Hayden F
    J Child Adolesc Psychopharmacol; 2001; 11(3):289-93. PubMed ID: 11642479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restless legs syndrome associated with the combined use of quetiapine and venlafaxine.
    Michopoulos I; Ferentinos P; Oulis P; Gournellis R
    J Clin Psychopharmacol; 2014 Feb; 34(1):159-61. PubMed ID: 24135842
    [No Abstract]   [Full Text] [Related]  

  • 54. Spotlight on quetiapine in bipolar depression.
    Keating GM; Robinson DM
    CNS Drugs; 2007; 21(8):695-7. PubMed ID: 17630822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Weight gain and improvement with quetiapine in bipolar I disorder: a case report.
    Ozcan ME; Kaya B; Polat R
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):413-5. PubMed ID: 14751443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
    Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
    Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacology of weight gain with antipsychotics.
    Casey DE; Zorn SH
    J Clin Psychiatry; 2001; 62 Suppl 7():4-10. PubMed ID: 11346195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quetiapine for Bipolar Depressive Episode in Obsessive-Compulsive Disorder Patients Maintained on Selective Serotonin Reuptake Inhibitor Treatment.
    Poyurovsky M; Weizman A
    Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):123-125. PubMed ID: 33811191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of problematic internet use successfully treated with an SSRI-antipsychotic combination.
    Atmaca M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):961-2. PubMed ID: 17321659
    [No Abstract]   [Full Text] [Related]  

  • 60. New findings from longitudinal and treatment studies in youth.
    Wagner KD
    J Clin Psychiatry; 2013 Jan; 74(1):57-8. PubMed ID: 23419227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.